EUVIMEDEUVIMED entdecken
Open Access

Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths

Mariela Cortés-López, Paulina Chamely, Allegra G Hawkins, Robert F Stanley, Ariel D Swett, Saravanan Ganesan, Tarek H Mouhieddine, Xiaoguang Dai, Lloyd Kluegel, Celine Chen, Kiran Batta, Nili Furer und 22 weitere

Cell Stem Cell · 2023

DOI: 10.1016/j.stem.2023.07.012 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Stem Cell, 2023. Verfasst von Mariela Cortés-López und 33 weiteren Autor:innen. Beteiligte Einrichtung: New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell…. Hauptthemen laut MEDLINE: RNA Splice Sites, Myelodysplastic Syndromes. Die Arbeit wurde bisher 64-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA Splice SitesMyelodysplastic SyndromesHumansMultiomicsRNA SplicingRNA Splicing FactorsMutationPhosphoproteins

Stichwörter der Autor:innen

BAXRNA-seqSF3B1clonal hematopoiesisgenotypinglong-read sequencingmulti-omicsmyelodysplastic syndromesingle cellsplicing

Substanzen

RNA Splice SitesRNA Splicing FactorsPhosphoproteins

Autor:innen und Institutionen

  • New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA.
  • Childhood Cancer Data Lab, Alex's Lemonade Stand Foundation, Philadelphia, PA, USA.
  • Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Oxford Nanopore Technologies Inc., New York, NY, USA.
  • New York Genome Center, New York, NY, USA; Division of Hematology and Medical Oncology, Department of Medicine and Meyer Cancer Center, Weill Cornell Medicine, New York, NY, USA; Tri-Institutional MD-PhD Program, Weill…

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • NHGRI NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Cortés-López, M., Chamely, P., Hawkins, A. G., Stanley, R. F., Swett, A. D., Ganesan, S., Mouhieddine, T. H., Dai, X., Kluegel, L., Chen, C., Batta, K., Furer, N., Vedula, R. S., Beaulaurier, J., Drong, A. W., Hickey, S., Dusaj, N., Mullokandov, G., Stasiw, A. M., …, & Landau, D. A. (2023). Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths. Cell Stem Cell. https://doi.org/10.1016/j.stem.2023.07.012

Vancouver

Cortés-López M, Chamely P, Hawkins AG, Stanley RF, Swett AD, Ganesan S, et al. Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths. Cell Stem Cell. 2023. doi:10.1016/j.stem.2023.07.012

BibTeX
@article{CortsLpez2023,
  author = {Cortés-López, Mariela and Chamely, Paulina and Hawkins, Allegra G and Stanley, Robert F and Swett, Ariel D and Ganesan, Saravanan and Mouhieddine, Tarek H and Dai, Xiaoguang and Kluegel, Lloyd and Chen, Celine and Batta, Kiran and Furer, Nili and Vedula, Rahul S and Beaulaurier, John and Drong, Alexander W and Hickey, Scott and Dusaj, Neville and Mullokandov, Gavriel and Stasiw, Adam M and Su, Jiayu and Chaligné, Ronan and Juul, Sissel and Harrington, Eoghan and Knowles, David A and Potenski, Catherine J and Wiseman, Daniel H and Tanay, Amos and Shlush, Liran and Lindsley, Robert C and Ghobrial, Irene M and Taylor, Justin and Abdel-Wahab, Omar and Gaiti, Federico and Landau, Dan A},
  title = {Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths},
  journal = {Cell Stem Cell},
  year = {2023},
  doi = {10.1016/j.stem.2023.07.012}
}
Kostenlos starten →